Cholesteatoma 2

  • Upload
    -

  • View
    223

  • Download
    0

Embed Size (px)

Citation preview

  • 8/6/2019 Cholesteatoma 2

    1/32

    CholesteatomaCholesteatoma--Pathogenesis andPathogenesis andSurgical ManagementSurgical Management

    Grand Rounds PresentationGrand Rounds Presentation

    February 24, 1999February 24, 1999

    Kyle Kennedy, M.D.Kyle Kennedy, M.D.

    Jeffrey Vrabec, M.D.Jeffrey Vrabec, M.D.

  • 8/6/2019 Cholesteatoma 2

    2/32

    IntroductionIntroduction

    Cholesteatoma (keratoma)Cholesteatoma (keratoma)--essentiallyessentially

    an accumulation of skin in ME/mastoidan accumulation of skin in ME/mastoid

    insidious natureinsidious nature

    variable symptoms depending on extentvariable symptoms depending on extent

    and location of diseaseand location of disease

    primarily a surgical diseaseprimarily a surgical disease

    high rate of recidivistic diseasehigh rate of recidivistic disease

    longlong--term followterm follow--up essentialup essential

  • 8/6/2019 Cholesteatoma 2

    3/32

    IntroductionIntroduction

    Pathology and classificationPathology and classification

    Eustachian tube dysfunctionEustachian tube dysfunction

    PathogenesisPathogenesis

    Anatomic considerationsAnatomic considerations

    EvaluationEvaluation

    Surgical managementSurgical management

    Results of therapyResults of therapy

    ComplicationsComplications

  • 8/6/2019 Cholesteatoma 2

    4/32

    Pathology and ClassificationPathology and Classification

    NonNon--neoplastic accumulation ofneoplastic accumulation of

    keratinizing stratified squamouskeratinizing stratified squamous

    epithelium with desquamated keratinepithelium with desquamated keratindebrisdebris

    Subepithelial fibroconnective tissueSubepithelial fibroconnective tissue

    Granulation tissueGranulation tissue Bone destruction possibleBone destruction possible

    Elaboration of collagenase and otherElaboration of collagenase and other

    inflammatory mediatorsinflammatory mediators

  • 8/6/2019 Cholesteatoma 2

    5/32

    Pathology and ClassificationPathology and Classification

    Congenital cholesteatomaCongenital cholesteatoma

    Acquired cholesteatomaAcquired cholesteatoma

    Canal cholesteatomaCanal cholesteatoma

  • 8/6/2019 Cholesteatoma 2

    6/32

    Congenital CholesteatomaCongenital Cholesteatoma

    Cholesteatoma sac medial to an intactCholesteatoma sac medial to an intact

    tympanic membranetympanic membrane

    Normal pars flaccida and tensaNormal pars flaccida and tensa

    No h/o TM perforation or otorrheaNo h/o TM perforation or otorrhea

    No h/o otologic trauma or surgeryNo h/o otologic trauma or surgery

    H/o prior episodes of OM does notH/o prior episodes of OM does not

    preclude its presencepreclude its presence

  • 8/6/2019 Cholesteatoma 2

    7/32

    Acquired CholesteatomaAcquired Cholesteatoma

    Usually found in posterosuperiorUsually found in posterosuperior

    quadrant of TM with asso. retractionquadrant of TM with asso. retraction

    pocket or perforationpocket or perforation Primary acquired cholesteatoma asso.Primary acquired cholesteatoma asso.

    with prewith pre--existing retraction pocketexisting retraction pocket

    Secondary acquired cholesteatomaSecondary acquired cholesteatomaarises in setting of persistent TMarises in setting of persistent TM

    perforationperforation

  • 8/6/2019 Cholesteatoma 2

    8/32

    Canal CholesteatomaCanal Cholesteatoma

    Found lateral to TMFound lateral to TM

    Idiopathic, postIdiopathic, post--traumatic, andtraumatic, and

    iatrogenic variantsiatrogenic variants

    Must be distinguished from keratosisMust be distinguished from keratosis

    obturansobturans

  • 8/6/2019 Cholesteatoma 2

    9/32

    Eustachian Tube DysfunctionEustachian Tube Dysfunction

    Important in pathogenesis of middle earImportant in pathogenesis of middle ear

    disease and cholesteatomadisease and cholesteatoma

    Essential role in recurrent disease andEssential role in recurrent disease andsurgical failuresurgical failure

    Preoperative clinical assessment ofPreoperative clinical assessment of

    tubal patency mandatorytubal patency mandatory Tubal function and ME aerationTubal function and ME aeration

    particularly important in postoperativeparticularly important in postoperative

    hearing results

    hearing results

  • 8/6/2019 Cholesteatoma 2

    10/32

    PathogenesisPathogenesis

    Migratory nature of TM epithelium andMigratory nature of TM epithelium and

    cholesteatomacholesteatoma

    Iatrogenic implantationIatrogenic implantation

    Invasion of squamous epitheliumInvasion of squamous epithelium

    Invagination theoryInvagination theory

    Basal cell proliferationBasal cell proliferation

    MetaplasiaMetaplasia

    Embryonic squamous epithelial cellEmbryonic squamous epithelial cell

    restsrests

  • 8/6/2019 Cholesteatoma 2

    11/32

    Anatomic ConsiderationsAnatomic Considerations

    Tympanic cavity derived fromTympanic cavity derived from

    endodermallyendodermally--lined first branchial pouchlined first branchial pouch

    Characteristic pathways of diseaseCharacteristic pathways of diseasespreadspread

    Attic or epitympanumAttic or epitympanum--Prussacks spacePrussacks space

    Posterior mesotympanumPosterior mesotympanum--facial recessfacial recessand sinus tympaniand sinus tympani

  • 8/6/2019 Cholesteatoma 2

    12/32

    EvaluationEvaluation

    HistoryHistory--longh/o ear complaintslongh/o ear complaints

    Physical examinationPhysical examination--otomicroscopyotomicroscopy

    AudiologyAudiology--CHLCHL

    ImagingImaging--assessment of mastoidassessment of mastoid

    disease, surgical road map, revisiondisease, surgical road map, revision

    cases, sensorineuralhearing loss,cases, sensorineuralhearing loss,vestibular symptomsvestibular symptoms

  • 8/6/2019 Cholesteatoma 2

    13/32

    ManagementManagement

    Surgical diseaseSurgical disease

    Patient age (I.e. pediatricPatient age (I.e. pediatric

    cholesteatoma generally consideredcholesteatoma generally consideredmore aggressive)more aggressive)

    Primary goal is eradication of diseasePrimary goal is eradication of disease

    withhearing preservation orwithhearing preservation orimprovement secondaryimprovement secondary

    Final therapeutic decisions often madeFinal therapeutic decisions often made

    at surgeryat surgery

  • 8/6/2019 Cholesteatoma 2

    14/32

  • 8/6/2019 Cholesteatoma 2

    15/32

    Surgical ManagementSurgical Management

    No consensus regarding optimalNo consensus regarding optimal

    surgical strategysurgical strategy

    Principal controversy concerning intactPrincipal controversy concerning intactcanal wall vs. canal wall downcanal wall vs. canal wall down

    mastoidectomymastoidectomy

    Therapy must be individualized onTherapy must be individualized oncasecase--byby--case basiscase basis

  • 8/6/2019 Cholesteatoma 2

    16/32

    Preoperative Patient CounselingPreoperative Patient Counseling

    Surgical goalsSurgical goals

    Risks of surgery including facialRisks of surgery including facial

    paralysis, tinnitus, vertigo, worsening ofparalysis, tinnitus, vertigo, worsening ofhearinghearing

    Possible need for staged procedurePossible need for staged procedure

    Chronic nature of disease process withChronic nature of disease process withneed for longneed for long--term followterm follow--upup

    Routine aural toilet if mastoid bowlRoutine aural toilet if mastoid bowl

    createdcreated

  • 8/6/2019 Cholesteatoma 2

    17/32

    Tympanostomy Tube InsertionTympanostomy Tube Insertion

    Alleviation of early TM retraction inAlleviation of early TM retraction in

    setting of ETDsetting of ETD

    Arrest pathologic process prior toArrest pathologic process prior toirreversible changes such asirreversible changes such as

    atelectasis, deep retraction pocketatelectasis, deep retraction pocket

    formation, TM perforation, orformation, TM perforation, orcholesteatoma formationcholesteatoma formation

    Assist in maintenance of ME aerationAssist in maintenance of ME aeration

    after tympanoplasty orafter tympanoplasty or

    t m anomastoidectomt m anomastoidectom

  • 8/6/2019 Cholesteatoma 2

    18/32

    TympanomeatalTympanomeatal

    Flap/TympanoplastyFlap/Tympanoplasty

    Smaller congenital cholesteatomas ofSmaller congenital cholesteatomas of

    involving TM or MEinvolving TM or ME

    Acquired cholesteatomas limited toAcquired cholesteatomas limited tomesotympanummesotympanum

  • 8/6/2019 Cholesteatoma 2

    19/32

    Intact Canal Wall MastoidectomyIntact Canal Wall Mastoidectomy

    Preservation of posterior canal wallPreservation of posterior canal wall

    during simple mastoidectomy with orduring simple mastoidectomy with or

    without posterior tympanotomy (facialwithout posterior tympanotomy (facialrecess approach)recess approach)

    Cholesteatomas of attic, antrum, post.Cholesteatomas of attic, antrum, post.

    mesotympanum with adequate ME andmesotympanum with adequate ME andmastoid aerationmastoid aeration

    Staging necessary with ME mucosalStaging necessary with ME mucosal

    abnormalities, ossicular erosion,abnormalities, ossicular erosion,

    residual diseaseresidual disease

  • 8/6/2019 Cholesteatoma 2

    20/32

    Canal Wall DownCanal Wall Down

    MastoidectomyMastoidectomy

    Removal of post. canal wall to level ofRemoval of post. canal wall to level of

    vertical facial nervevertical facial nerve

    Creation of mastoid cavity withCreation of mastoid cavity withexteriorization of mastoid into EACexteriorization of mastoid into EAC

    Scutum removed with obliteration ofScutum removed with obliteration of

    epitympanum and removal of malleusepitympanum and removal of malleushead and incushead and incus

    MRM ME space maintained whileMRM ME space maintained while

    radical mastoid eliminates ME spaceradical mastoid eliminates ME space

  • 8/6/2019 Cholesteatoma 2

    21/32

    Canal Wall DownCanal Wall Down

    MastoidectomyMastoidectomy

    Surgery in an onlySurgery in an only--hearing earhearing ear

    Poor anesthetic riskPoor anesthetic risk

    Poor pt compliance with unreliable F/UPoor pt compliance with unreliable F/U

    Poor tubal function and ME aerationPoor tubal function and ME aeration

    Sclerotic mastoidSclerotic mastoid

    Extensive canal wall defectExtensive canal wall defect

    Labyrinthine fistulaLabyrinthine fistula

    Meatoplasty and mastoid obliterationMeatoplasty and mastoid obliteration

  • 8/6/2019 Cholesteatoma 2

    22/32

    AtticotomyAtticotomy

    Removal of scutumRemoval of scutum

    Limited attic diseaseLimited attic disease

    Scutal reconstruction with autologousScutal reconstruction with autologous

    cartilagecartilage

  • 8/6/2019 Cholesteatoma 2

    23/32

    Bondy ProcedureBondy Procedure

    Removal of scutum and posterior canalRemoval of scutum and posterior canal

    wall with preservation of ossicles andwall with preservation of ossicles and

    ME spaceME space Larger attic cholesteatomas lateral toLarger attic cholesteatomas lateral to

    ossicles in pt with sclerotic mastoidossicles in pt with sclerotic mastoid

  • 8/6/2019 Cholesteatoma 2

    24/32

    Intact Canal WallAdvantagesIntact Canal WallAdvantages

    More rapidhealingMore rapidhealing

    Easier longEasier long--term postoperative careterm postoperative care

    No water precautions necessaryNo water precautions necessary

    (particularly important in children)(particularly important in children)

    More options available forhearing aid, ifMore options available forhearing aid, if

    necessarynecessary

  • 8/6/2019 Cholesteatoma 2

    25/32

    Intact Canal Wall DisadvantagesIntact Canal Wall Disadvantages

    Epitympanum/mastoid not accessible toEpitympanum/mastoid not accessible to

    postop inspectionpostop inspection

    Supratubal space not easily accessibleSupratubal space not easily accessibleunless malleus head and incus removedunless malleus head and incus removed

    Both residual and recurrent diseaseBoth residual and recurrent disease

    more likelymore likely Greater number of procedures usuallyGreater number of procedures usually

    required for disease eradicationrequired for disease eradication

  • 8/6/2019 Cholesteatoma 2

    26/32

    Canal Wall Down AdvantagesCanal Wall Down Advantages

    Easy detection of residual diseaseEasy detection of residual disease

    Recurrent cholesteatoma rareRecurrent cholesteatoma rare

    Fewer procedures necessary forFewer procedures necessary for

    eradication of diseaseeradication of disease

  • 8/6/2019 Cholesteatoma 2

    27/32

    Canal Wall Down DisadvantagesCanal Wall Down Disadvantages

    Longerhealing timeLongerhealing time

    Special cavity care often necessary forSpecial cavity care often necessary for

    properhealingproperhealing

    Periodic cleaning necessaryPeriodic cleaning necessary

    Accumulation of debris may occur withAccumulation of debris may occur with

    increased risk of infectionincreased risk of infection Water precautions necessaryWater precautions necessary

  • 8/6/2019 Cholesteatoma 2

    28/32

    Results of TherapyResults of Therapy

    Rosenberg et al. examined variablesRosenberg et al. examined variables

    with regard to residualwith regard to residual--recurrentrecurrent

    disease (retrospective)disease (retrospective) 232 children with cholesteatoma (244232 children with cholesteatoma (244

    ears)ears)

    Ossicular erosion asso. with residualOssicular erosion asso. with residual--recurrent disease (necessitates 2ndrecurrent disease (necessitates 2nd

    look)look)

    Recidivism 61% at 6 yearsRecidivism 61% at 6 years--

  • 8/6/2019 Cholesteatoma 2

    29/32

    Results of TherapyResults of Therapy

    Dodson et al. examined cases of 66Dodson et al. examined cases of 66

    children with cholesteatoma (73 ears)children with cholesteatoma (73 ears)

    retrospectively with ave. F/U37.7 mos.retrospectively with ave. F/U37.7 mos. ICWICW--41% recidivism andCWD41% recidivism andCWD--12%12%

    recidivismrecidivism

    Postop SRT less than 30 dB in 75% ofPostop SRT less than 30 dB in 75% ofICW and 72% ofCWDICW and 72% ofCWD

    Prefer ICW with 2nd stagePrefer ICW with 2nd stage

  • 8/6/2019 Cholesteatoma 2

    30/32

    Results of TherapyResults of Therapy

    Hirsch et al. retro. reviewed 164 casesHirsch et al. retro. reviewed 164 cases

    of ped. chol. (116 avail. for 5 year F/U)of ped. chol. (116 avail. for 5 year F/U)

    Majority of pts requiredCWD procedureMajority of pts requiredCWD procedure

    Recidivism 11% for tympanoplasty, 19%Recidivism 11% for tympanoplasty, 19%

    for ICW, 5% for MRM, and 0% forfor ICW, 5% for MRM, and 0% for

    radical mastoidradical mastoidAlso reported fewer revisions and betterAlso reported fewer revisions and better

    hearing results withCWDhearing results withCWD

  • 8/6/2019 Cholesteatoma 2

    31/32

    ComplicationsComplications

    Conductive hearing lossConductive hearing loss

    Labyrinthine fistulaLabyrinthine fistula

    Facial nerve paresis or paralysisFacial nerve paresis or paralysis

    Intratemporal or intracranialIntratemporal or intracranial

    complicationscomplications

    EncephaloceleEncephalocele

  • 8/6/2019 Cholesteatoma 2

    32/32

    ConclusionsConclusions

    Exact pathogenesis not entirely clearExact pathogenesis not entirely clear

    Important anatomic considerations inImportant anatomic considerations in

    managementmanagement

    Eradication of disease primary goalEradication of disease primary goal

    No universally accepted surgicalNo universally accepted surgical

    strategystrategy High rate of recidivism with longHigh rate of recidivism with long--termterm

    F/UessentialF/Uessential

    Maintain vigilance for complicationsMaintain vigilance for complications